Madrigal Pharmaceuticals, Inc.
MDGL· Nasdaq
Released May 10, 2016, before the open
10-Q filed May 10, 2016, 40 days after period end · 0001104659-16-119512
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2016 | Q1 2015 | Q1 2014 | Q1 2013 |
|---|---|---|---|---|
| EPS Diluted | -$9.72 | -$0.19 | -$0.28 | -$0.30 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Madrigal Pharmaceuticals, Inc. · CIK 1157601 · Engraved from SEC EDGAR
ended Mar 31, 2016 · filed May 10, 2016 · 40 d after period end